FIIs and DIIs are piling into these four pharma stocks. Should you follow?

While rising institutional stakes highlight growing smart-money confidence in pharma, retail investors must weigh valuations, growth drivers, and regulatory risks before deciding…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.livemint.com)